The Life Sciences industry is an especially exciting industry for simulation today!  I look forward to you joining me in this 30minute session.

My Presentation

The rates of adoption and integration of simulation into product development business processes is accelerating as the industry starts to more aggressively capitalize on the opportunities that simulation represents. Strongly motivated by the needs to control ever increasing development costs, to minimize patient risk, and simultaneously innovate new therapies, the industry is trying to change it’s physical test dominated model to one that relies on a more equitable balance of physical and virtual validation methods. We support this; the regulatory bodies support this; and the industry needs this!